Delivery Order SPE2DB20D1109-SPE2DB25FP85F
Award Date 9/26/25
Potential Completion Date 9/29/25
Potential Value $43K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 3, 2025, valued at $91,328.55 for RINVOQ ER 15 mg tablets (30-count units) under a firm fixed price contract type. The award, issued by the Defense Logistics Agency (DLA), was competitively awarded with no set-aside designation and has an ultimate completion date of September 4, 2025. This delivery order serves as a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 25, 2025, for RINVOQ ER 30 mg tablets (30-count units) with a ceiling value of $14,445.38. This firm fixed-price delivery order, which has an ultimate completion date of September 26, 2025, was competitively awarded without any set-aside designation. The contract represents a specific fulfillment under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on July 30, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose) valued at $11,415.23. This firm fixed-price contract award was competitively procured with no set-aside designation and carries an ultimate completion date of July 31, 2025. The delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, which procures...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 2, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply RINVOQ ER 30 mg tablets in quantities of 30-unit packages. The contract is valued at $7,943.17 with a firm fixed price structure and an ultimate completion date of September 3, 2025. This is a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $14,917.09 for RINVOQ ER 30 MG Tablet (UU 30s) by the Defense Logistics Agency Medical Supply Chain. The contract, awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, utilizes firm fixed pricing and is classified as a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,605.35 on August 20, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order contract from the Defense Logistics Agency (DLA) on September 18, 2025, valued at $16,823.38 for RINVOQ ER 15 mg tablets (30-count units). This firm fixed-price delivery order was competitively awarded with no set-aside designation and carries an ultimate completion date of September 19, 2025. The award is issued as a child contract under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 14, 2025, for the supply of RINVOQ ER 15 MG tablets in a quantity of 30 units. This $6,317.05 firm fixed price delivery order is unclassified as a set-aside contract and represents a competitive award under the company's larger pharmaceutical supply vehicle with DLA. The contract is scheduled for completion by August 15, 2025, with performance taking...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $22,973.88 by the Defense Logistics Agency for the supply of RINVOQ ER 15 MG tablets in packages of 30. The contract, awarded on July 14, 2025, represents a firm fixed price delivery order with an ultimate completion date of July 15, 2025. This award was made through open competition with no set-aside designation. The delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for RINVOQ ER 30 mg tablets (30-unit packages) valued at $10,378.45. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by July 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the primary vendor fulfilling this pharmaceutical requirement through its...